The global market for Intrathecal Pumps was estimated at US$262.5 Million in 2023 and is projected to reach US$369.9 Million by 2030, growing at a CAGR of 5.0% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. ![Intrathecal Pumps Market]( "Intrathecal Pumps Market")
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Morphine segment, which is expected to reach US$115.9 Million by 2030 with a CAGR of a 4.9%. The Ziconotide segment is also set to grow at 5.6% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, which was estimated at $71.4 Million in 2023, and China, forecasted to grow at an impressive 4.8% CAGR to reach $58.8 Million by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Intrathecal Pumps Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Intrathecal Pumps Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Intrathecal Pumps Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players such as Advance Neuromodulation System, Advanced Bionics, Arrow International, and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Select Competitors (Total 42 Featured):
- Advance Neuromodulation System
- Advanced Bionics
- Arrow International
- Baxter
- Boston Scientific
- Codman & Shurtleff
- DJO Global
- Dynacast
- Flowonix Medical
- Inteprod
- Johnson and Johnson Services, Inc.
- Medallion Therapeutics
- Medasys
- Medtronic plc
- Perlong Medical Equipment
- Qinhuangdao Sanwin Trading
- Smiths Medical
- St. Jude Medical
- Stryker
- Teleflex
- Tricumed
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Intrathecal Pumps - Global Key Competitors Percentage Market Share in 2024 (E)
- Global Economic Update
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
3. MARKET TRENDS & DRIVERS
- Growing Demand for Pain Management Solutions Spurs Adoption of Intrathecal Pumps
- Advancements in Pump Technology Propel Innovation in Intrathecal Drug Delivery
- Shift Towards Minimally Invasive Pain Management Expands Market Opportunities
- Increasing Use of Intrathecal Pumps in Treating Chronic Pain and Spasticity
- Role of Intrathecal Pumps in Reducing Opioid Consumption
- Growing Importance of Personalized Pain Management Solutions
- Advancements in Implantable Devices Propel Market Growth
- Emerging Markets Present New Opportunities for Intrathecal Pump Manufacturers
- Push for Cost-Effective and Long-Term Pain Relief Solutions
- Role of Intrathecal Pumps in Enhancing Quality of Life for Patients with Severe Pain
4. GLOBAL MARKET PERSPECTIVE
- TABLE 1: World Intrathecal Pumps Market Analysis of Annual Sales in US$ for Years 2014 through 2030
- TABLE 2: World Recent Past, Current & Future Analysis for Intrathecal Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 3: World Historic Review for Intrathecal Pumps by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 4: World 16-Year Perspective for Intrathecal Pumps by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
- TABLE 5: World Recent Past, Current & Future Analysis for Morphine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 6: World Historic Review for Morphine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 7: World 16-Year Perspective for Morphine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 8: World Recent Past, Current & Future Analysis for Ziconotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 9: World Historic Review for Ziconotide by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 10: World 16-Year Perspective for Ziconotide by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 11: World Recent Past, Current & Future Analysis for Baclofen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 12: World Historic Review for Baclofen by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 13: World 16-Year Perspective for Baclofen by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 14: World Recent Past, Current & Future Analysis for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 15: World Historic Review for Bupivacaine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 16: World 16-Year Perspective for Bupivacaine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 17: World Recent Past, Current & Future Analysis for Clonidine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 18: World Historic Review for Clonidine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 19: World 16-Year Perspective for Clonidine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 20: World Recent Past, Current & Future Analysis for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 21: World Historic Review for Other Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 22: World 16-Year Perspective for Other Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 23: World Recent Past, Current & Future Analysis for Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 24: World Historic Review for Pain by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 25: World 16-Year Perspective for Pain by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
- TABLE 26: World Recent Past, Current & Future Analysis for Spasticity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 27: World Historic Review for Spasticity by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 28: World 16-Year Perspective for Spasticity by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
UNITED STATES
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
- TABLE 29: USA Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 30: USA Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 31: USA 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 32: USA Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 33: USA Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 34: USA 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
CANADA
- TABLE 35: Canada Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 36: Canada Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 37: Canada 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 38: Canada Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 39: Canada Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 40: Canada 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
JAPAN
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
- TABLE 41: Japan Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 42: Japan Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 43: Japan 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 44: Japan Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 45: Japan Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 46: Japan 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
CHINA
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
- TABLE 47: China Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 48: China Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 49: China 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 50: China Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 51: China Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 52: China 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
EUROPE
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
- TABLE 53: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 54: Europe Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 55: Europe 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 56: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
- TABLE 57: Europe Historic Review for Intrathecal Pumps by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 58: Europe 16-Year Perspective for Intrathecal Pumps by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
- TABLE 59: Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 60: Europe Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 61: Europe 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
FRANCE
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
- TABLE 62: France Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 63: France Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 64: France 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 65: France Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 66: France Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 67: France 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
GERMANY
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
- TABLE 68: Germany Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 69: Germany Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 70: Germany 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 71: Germany Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 72: Germany Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 73: Germany 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
ITALY
- TABLE 74: Italy Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 75: Italy Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 76: Italy 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 77: Italy Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 78: Italy Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 79: Italy 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
UNITED KINGDOM
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
- TABLE 80: UK Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 81: UK Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 82: UK 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 83: UK Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 84: UK Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 85: UK 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
REST OF EUROPE
- TABLE 86: Rest of Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 87: Rest of Europe Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 88: Rest of Europe 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 90: Rest of Europe Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 91: Rest of Europe 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
ASIA-PACIFIC
- Intrathecal Pumps Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
- TABLE 92: Asia-Pacific Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 93: Asia-Pacific Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 94: Asia-Pacific 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 96: Asia-Pacific Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 97: Asia-Pacific 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
REST OF WORLD
- TABLE 98: Rest of World Recent Past, Current & Future Analysis for Intrathecal Pumps by Application - Pain and Spasticity - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 99: Rest of World Historic Review for Intrathecal Pumps by Application - Pain and Spasticity Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 100: Rest of World 16-Year Perspective for Intrathecal Pumps by Application - Percentage Breakdown of Value Sales for Pain and Spasticity for the Years 2014, 2024 & 2030
- TABLE 101: Rest of World Recent Past, Current & Future Analysis for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
- TABLE 102: Rest of World Historic Review for Intrathecal Pumps by Type - Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
- TABLE 103: Rest of World 16-Year Perspective for Intrathecal Pumps by Type - Percentage Breakdown of Value Sales for Morphine, Ziconotide, Baclofen, Bupivacaine, Clonidine and Other Types for the Years 2014, 2024 & 2030
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Advance Neuromodulation System
- Advanced Bionics
- Arrow International
- Baxter
- Boston Scientific
- Codman & Shurtleff
- DJO Global
- Dynacast
- Flowonix Medical
- Inteprod
- Johnson and Johnson Services, Inc.
- Medallion Therapeutics
- Medasys
- Medtronic plc
- Perlong Medical Equipment
- Qinhuangdao Sanwin Trading
- Smiths Medical
- St. Jude Medical
- Stryker
- Teleflex
- Tricumed
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 194 |
| Published | October 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 262.5 Million |
| Forecasted Market Value ( USD | $ 369.9 Million |
| Compound Annual Growth Rate | 5.0% |
| Regions Covered | Global |
